Orphamed
Orphamed is a Dutch B2B pharmaceutical distributor that sources and delivers out-of-stock, licensed medications from a 10-country European supplier network to 300+ hospitals and pharmacies, using an in-house warehouse and a quote-based, pay-as-you-go model.
- Company typePrivate
- Founded-
- HeadquartersRoermond, Netherlands
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Orphamed does
Orphamed is a privately held Dutch pharmaceutical distribution company headquartered in Roermond, Netherlands, that sources and delivers difficult-to-obtain, licensed medications to pharmacies and hospitals across Europe. Its core service is a B2B shortage-resolution offering: customers email a list of out-of-stock products, Orphamed searches its European supplier network (spanning 10 EU countries), responds with availability within 24 hours, and ships on a fixed multi-weekly schedule. The company sells exclusively to institutional healthcare buyers and explicitly excludes consumer and general retail channels.
The underlying operation rests on three components: a curated network of European licensed pharmaceutical suppliers that enables cross-border sourcing, an in-house warehouse adjacent to the Roermond headquarters that bundles storage, quality control, and shipping, and a direct, email-driven order workflow. Product scope is broad within the shortage niche — 250+ different medications delivered in 2025 — including high-value biologics such as human fibrinogen and specialty items like Gliatilin and Prednisolut. The technology stack is traditional logistics rather than a software platform; there is no API, no AI/ML capability disclosed, and no app.
Commercially, Orphamed operates a sales-led, quote-based model with pay-as-you-go billing at market-conform prices. Revenue is generated per delivery rather than via subscriptions or licenses. Marketing is conducted through the company website, a LinkedIn presence, case-study-driven referrals, and selective industry events such as EAHP Boost. The customer base reached 300+ healthcare institutions across the Netherlands, Belgium, Germany, Italy, Poland, and Ireland in 2025, with approximately 1,600 deliveries completed and roughly 6 new partnerships added per week. No funding rounds, ownership disclosures, or revenue figures are publicly available.
Orphamed firmographics
Firmographics- Name
- Orphamed
- Legal name
- Orphamed
- Website
- https://orphamed.nl
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Orphamed is a Dutch B2B pharmaceutical distributor that sources and delivers out-of-stock, licensed medications from a 10-country European supplier network to 300+ hospitals and pharmacies, using an in-house warehouse and a quote-based, pay-as-you-go model.
- Ownership category
- akta.pro rank
Orphamed industry classification
Industry- Product category
- Pharmaceutical Distribution
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI)
Keywords
Where Orphamed is headquartered
LocationHeadquarters
- HQ city
- Roermond
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Orphamed business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Product Sales: Orphamed generates revenue by sourcing and selling difficult-to-obtain licensed medications to pharmacies and hospitals. They act as an intermediary in the pharmaceutical supply chain, finding unavailable medications through their European network and delivering them to healthcare institutions. The company handles inventory management, logistics, and availability of medications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Quote-based pricing for out-of-stock medications |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Orphamed product offering
Product offeringCore offering
Orphamed sources and delivers difficult-to-obtain licensed medications to pharmacies and hospitals across Europe. The company uses an extensive European supplier network to find unavailable or out-of-stock medicines, then delivers them through its in-house warehouse facility adjacent to its Roermond headquarters. Customers submit lists of needed medications via email, receive quotes within 24 hours, and have products delivered multiple times per week on fixed schedules.
Product overview
Orphamed offers a unified pharmaceutical supply service focused on difficult-to-obtain medications. Their core offering is a sourcing and delivery service that connects pharmacies and hospitals with a broad European supplier network. The company handles inventory management, logistics, and ensures availability of scarce medicines. They operate an in-house warehouse adjacent to their headquarters for improved operational efficiency. Their service portfolio centers on rapid international sourcing of out-of-stock medications, including critical and hard-to-find pharmaceuticals, with 250+ different medicines delivered and over 1,600 shipments completed in 2025.
Differentiator
Problem solved
Functional benefit
Products and services
- Difficult-to-Obtain Medicines Supply
Quantifiable outcome
- Continuity of care guaranteed for hospitals during medication shortages
- +3 more outcomes
Companies that use Orphamed
Customer profileNamed customers7 records
Segments2 records
Ideal customer profiles2 records
Orphamed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Orphamed partnerships and signals
Strategic signalScale indicators6 records
Recent moves8 records
Expansion highlights5 records
Orphamed competitors and assessment
Company assessmentDirect peers
- Durbin PLC: UK pharmaceutical distributor supplying unlicensed medicines, clinical trial supplies, and shortage products to hospitals and pharmacies—comparable niche overlap with Orphamed's specialty sourcing service.
- Clinigen Group: UK-based access-to-medicines company providing unlicensed and shortage pharmaceuticals to hospitals globally; highly comparable in that it brokers difficult-to-obtain drugs during supply disruptions, similar to Orphamed's hospital-facing service.
- WEP Clinical: Specialist access-to-medicines company supplying unlicensed, shortage, and expanded-access pharmaceuticals to hospitals and clinicians; a close functional peer to Orphamed in serving hard-to-obtain drug needs.
- Trident Pharmaceuticals: UK-based parallel pharmaceutical importer/distributor focused on supplying shortage and hard-to-obtain medicines to UK and EU hospital and pharmacy customers—a directly comparable specialty peer.
- B&B Pharmaceuticals: Irish pharmaceutical distributor focused on parallel import and shortage supply of medicines to hospitals and pharmacies in Ireland and the EU—directly comparable to Orphamed's European shortage-sourcing business.
- Mawdsley-Brooks & Co. UK-headquartered parallel pharmaceutical distributor that sources and supplies unlicensed, hard-to-obtain, and shortage medicines to hospitals and pharmacies across Europe—directly comparable to Orphamed's cross-border shortage-response model.
Broad incumbents
- Alliance Healthcare: One of the largest pharmaceutical wholesalers in Europe (Walgreens Boots Alliance subsidiary), distributing to pharmacies and hospitals across multiple countries; a broad incumbent against which Orphamed competes for hospital and pharmacy supply contracts.
- Phoenix Group: Pan-European pharmaceutical distribution group operating 160+ distribution centers; large-scale incumbent supplying pharmacies and hospitals and an obvious competitor for cross-border shortage supply.
- Tamro Group: Nordic pharmaceutical distributor serving pharmacies and hospitals across Northern Europe; a regional incumbent comparable in business model to Orphamed's hospital/pharmacy wholesale activity.
Regional players
- Esperant Healthcare: Netherlands-based pharmaceutical services company active in parallel trade and licensed medicine distribution across Europe; operates in the same home market as Orphamed and competes in adjacent supply channels.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Orphamed social profiles
Digital presenceOrphamed financial estimates
Financial estimateRevenue estimate
Valuation estimate
Orphamed leadership team
Management profileNumber of profiles
Orphamed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Orphamed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Orphamed
What does Orphamed do?
Orphamed sources and delivers difficult-to-obtain licensed medications to pharmacies and hospitals across Europe. The company uses an extensive European supplier network to find unavailable or out-of-stock medicines, then delivers them through its in-house warehouse facility adjacent to its Roermond headquarters. Customers submit lists of needed medications via email, receive quotes within 24 hours, and have products delivered multiple times per week on fixed schedules.
Is Orphamed a public or private company?
Orphamed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Orphamed founded?
Orphamed was founded in -1. It employs 11 to 50 people.
Where is Orphamed based?
Orphamed is headquartered in Roermond, Netherlands, in the Europe region.
How does Orphamed make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Orphamed's main competitors?
Direct peers on record are Durbin PLC, Clinigen Group, WEP Clinical, Trident Pharmaceuticals, B&B Pharmaceuticals and Mawdsley-Brooks & Co.. Broad incumbents are Alliance Healthcare, Phoenix Group and Tamro Group. Esperant Healthcare is listed as a regional player.
Does Orphamed have an API?
No public API is recorded for Orphamed.
What industry is Orphamed in?
Orphamed's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLACAKAI, Medication Inventory, Procurement & Supply Chain (Pharmacy). Its SIC code is 5122.